Brand-Name vs Compounded GLP-1: A 2026 Decision Framework Patients in 2026 have three realistic supply paths: insurance-covered brand-name (Wegovy, Zepbound, Ozempic, Mounjaro), cash-pay brand-name via manufacturer self-pay (Novo NovoCare, Lilly LillyDirect), and cash-pay compounded semaglutide or tirzepatide through US-licensed compounding pharmacies
Even in the states that do offer coverage, getting it isnt easy
The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin
Effect of cryopreservation and transplantation on the expression of kit ligand and anti-Mullerian hormone in human ovarian tissue
They complement our IV therapy infusions for patients who want a quick nutrient boost between full IV sessions, support our nutrition programs by addressing specific deficiencies, and are often used alongside our functional diagnostic testing once deficiencies are identified